PMID- 21843347 OWN - NLM STAT- MEDLINE DCOM- 20111212 LR - 20220318 IS - 1423-0127 (Electronic) IS - 1021-7770 (Print) IS - 1021-7770 (Linking) VI - 18 IP - 1 DP - 2011 Aug 15 TI - Lipopolysaccharide-induced Notch signaling activation through JNK-dependent pathway regulates inflammatory response. PG - 56 LID - 10.1186/1423-0127-18-56 [doi] AB - BACKGROUND: Notch and TLR pathways were found to act cooperatively to activate Notch target genes and to increase the production of TLR-induced cytokines in macrophages. However, the mechanism of LPS-induced Notch activation and its role in sepsis still remains unclear. METHODS: We analyzed the expression patterns of Notch components in a LPS-stimulated murine macrophage cell line using real-time PCR and western blotting. The role of DAPT, a gamma-secretase inhibitor that is known to be a potent Notch inhibitor, in LPS-induced cytokine release and experimental sepsis in mice was also explored. Student's t-test was used to analyze the difference between the two groups. RESULTS: We found that Notch signaling was activated after LPS stimulation. The expression of Jagged 1, a Notch ligand, induced by LPS occurred in a JNK-dependent manner. In addition, Notch target genes were upregulated by early Notch-independent activation followed by delayed Notch-dependent activation after LPS stimulation. Disruption of Notch signaling by DAPT attenuated the LPS-induced inflammatory responses, including vascular endothelial growth factor (VEGF) and high-mobility group box chromosomal protein 1 (HMGB1), both in vitro and in vivo and partially improved experimental sepsis survival. CONCLUSIONS: These findings support the existence of a synergistic effect of Notch signaling and the LPS pathway both in vitro and in vivo. Therefore, in the future Notch inhibitors may be utilized as adjunctive agents for the treatment of sepsis syndrome. FAU - Tsao, Po-Nien AU - Tsao PN AD - Department of Pediatrics, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. tsaopn@ntu.edu.tw FAU - Wei, Shu-Chen AU - Wei SC FAU - Huang, Miao-Tzu AU - Huang MT FAU - Lee, Ming-Cheng AU - Lee MC FAU - Chou, Hung-Chieh AU - Chou HC FAU - Chen, Chien-Yi AU - Chen CY FAU - Hsieh, Wu-Shiun AU - Hsieh WS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110815 PL - England TA - J Biomed Sci JT - Journal of biomedical science JID - 9421567 RN - 0 (Calcium-Binding Proteins) RN - 0 (Cytokines) RN - 0 (Dipeptides) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Jag1 protein, mouse) RN - 0 (Jagged-1 Protein) RN - 0 (Lipopolysaccharides) RN - 0 (Membrane Proteins) RN - 0 (N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester) RN - 0 (Receptors, Notch) RN - 0 (Serrate-Jagged Proteins) RN - 0 (Toll-Like Receptors) RN - EC 2.7.12.2 (MAP Kinase Kinase 4) SB - IM MH - Animals MH - Blotting, Western MH - Calcium-Binding Proteins/metabolism MH - Cytokines/biosynthesis MH - Dipeptides/pharmacology MH - Intercellular Signaling Peptides and Proteins/metabolism MH - Jagged-1 Protein MH - Lipopolysaccharides MH - MAP Kinase Kinase 4/*metabolism MH - Macrophages MH - Membrane Proteins/metabolism MH - Mice MH - Real-Time Polymerase Chain Reaction MH - Receptors, Notch/antagonists & inhibitors/*metabolism MH - Serrate-Jagged Proteins MH - Signal Transduction/drug effects/*physiology MH - Systemic Inflammatory Response Syndrome/*metabolism MH - Toll-Like Receptors/*metabolism PMC - PMC3176188 EDAT- 2011/08/17 06:00 MHDA- 2011/12/14 06:00 PMCR- 2011/08/15 CRDT- 2011/08/17 06:00 PHST- 2011/04/22 00:00 [received] PHST- 2011/08/15 00:00 [accepted] PHST- 2011/08/17 06:00 [entrez] PHST- 2011/08/17 06:00 [pubmed] PHST- 2011/12/14 06:00 [medline] PHST- 2011/08/15 00:00 [pmc-release] AID - 1423-0127-18-56 [pii] AID - 10.1186/1423-0127-18-56 [doi] PST - epublish SO - J Biomed Sci. 2011 Aug 15;18(1):56. doi: 10.1186/1423-0127-18-56.